Company profilePharmaceutical#247 of 1,318 in Pakistan✓ No DRAP alerts

Schazoo Laboratories (Pvt) Ltd

Pharmaceutical company · 74 brands · 120 molecules

Ranked #9 of 23 companies in Eye Conditions

74 registered products 28 pharmaceutical brands 120 distinct molecules 0 DRAP alerts

Company overview

74
registered products
28
pharmaceutical brands
120
distinct molecules
11
therapeutic classes
0
DRAP alerts

Schazoo Laboratories (Pvt) Ltd is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 74 product registrations across 120 distinct molecules. Its portfolio is concentrated in Eye Conditions and Allergy. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Schazoo

17 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Eye17 brands
Rifampicin3 brands
Isoniazid3 brands
Prednisolone3 brands
Nasal3 brands
Naphazoline3 brands
Tobramycin3 brands
Ketotifen2 brands
Terbinafine2 brands
Inh 75 Mg2 brands

Therapeutic classes

Eye Conditions · 8Allergy · 5Anti-Infective, Ophthalmologicals · 5Immunosuppressants · 4Antimycobacterials (Antituberculosis) · 3Decongestants And Antiallergics · 3Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 3Antiepileptics · 3Antiglaucoma Preparations And Miotics · 2Antihistamines For Systemic Use · 2Cardiac Care · 2

Conditions treated

Tuberculosis · 4Nasal Congestion · 3Allergy/Infections · 3Conventional Agents · 2Dry Eye/Allergy · 2Glaucoma/Mydriasis · 2PAIN · 1Arthritis · 1Oral Agents · 1Hypertension · 1Anxiety/Depression/Insomnia · 1Auto Immune Disease · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official21 products · Rs 6.68 – Rs 6,406.7
DVAGO11 products · Rs 125 – Rs 675
Servaid34 products · Rs 59 – Rs 3,465.9
Median across source: Rs 328.6

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Genix Pharma Private Limited holds 152 molecules not in this portfolio
000 I.UAceclofenacAcyclovirAlbendazoleAlfacalcidolAmikacin
HELIX PHARMA (PRIVATE) LIMITED holds 109 molecules not in this portfolio
000 I.UAmlodipineAmylaseArtemetherArtesunateAscorbic Acid
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 151 molecules not in this portfolio
AlbuterolAmikacinAminophyllineAmlodipineAmlodipine BaseAmmonium Chloride

Get the full profile for Schazoo

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.